Nu Skin Enterprises, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NUS research report →
Companywww.nuskin.com
Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.
- CEO
- Ryan S. Napierski
- IPO
- 1996
- Employees
- 3,100
- HQ
- Provo, UT, US
Price Chart
Valuation
- Market Cap
- $283.54M
- P/E
- 5.16
- P/S
- 0.20
- P/B
- 0.35
- EV/EBITDA
- 2.80
- Div Yield
- 4.11%
Profitability
- Gross Margin
- 69.31%
- Op Margin
- 5.66%
- Net Margin
- 3.78%
- ROE
- 6.84%
- ROIC
- 6.08%
Growth & Income
- Revenue
- $1.49B · -14.26%
- Net Income
- $160.20M · 209.28%
- EPS
- $3.25 · 210.17%
- Op Income
- $90.88M
- FCF YoY
- -34.42%
Performance & Tape
- 52W High
- $14.62
- 52W Low
- $5.67
- 50D MA
- $7.20
- 200D MA
- $9.64
- Beta
- 1.02
- Avg Volume
- 530.95K
Get TickerSpark's AI analysis on NUS
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 11, 26 | Nathanson Laura | sell | 2,676 |
| Mar 18, 26 | Lantz Chelsea K | other | 0 |
| Mar 11, 26 | WOODBURY EDWINA D | other | 14 |
| Mar 6, 26 | Keisel Justin S | other | 47,059 |
| Mar 6, 26 | Hatchett Steven Keith | other | 77,941 |
| Mar 6, 26 | Clark Chayce David | other | 138,971 |
| Mar 6, 26 | Thomas James D | other | 114,706 |
| Mar 6, 26 | NAPIERSKI RYAN S | other | 282,353 |
| Feb 26, 26 | Keisel Justin S | other | 13,687 |
| Feb 26, 26 | Hatchett Steven Keith | other | 26,001 |
Our NUS Coverage
We haven't published any research on NUS yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate NUS Report →